x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
White Paper

Understanding the Current and Future States of Cell and Gene Therapy Research

This white paper focuses on gene therapy uses in oncology and looks at a successful program at an NCI-designated comprehensive cancer center.

Read Now
Read more
 
Webinar

Is Your Site Ready to Conduct Gene Therapy Research?

June 15, 2021

Watch Now
Read more
 
News

Advarra Announces Key Growth Milestone for The Gene Therapy Ready Network, Becoming Largest IBC Service

Advarra's network has grown to over 500 registered research sites, becomes the largest administrator of institutional biosafety committees

Read Now
3 min. read
Read more
 
Blog

Cell & Gene Therapy vs Drug Research: What’s the Difference?

In the past year, cell and gene therapy research has exploded. Understand how this field differs from traditional drug development.

Read Now
3 min. read
Read more
 
E-Learning

IBC Overview eLearning Module

Institutional biosafety committee oversight is necessary to ensure the safety of those involved in research with engineered genetic materials.

Read Now
Read more
 
Podcast

Daniel Eisenman, Paul Gulig, and Adam Soloff Explore The Exponential Rise of Gene Therapy and Unlocking Its Potential Promise

In this podcast, Daniel Eisenmann talks with Adam Soloff and Paul Gulig for a discussion on the growth and the promise of gene therapy.  

Listen Now
Read more
 
Blog

Improving Study Activation Time for Gene Therapy Research

With the growing popularity of gene therapy research and genetically engineered vaccines, sites need to understand study activation impacts

Read Now
5 min. read
Read more
 
Blog

Pitfalls of Chemistry, Manufacturing, and Controls in Investigational New Drug Preparation

Submitting an Investigational New Drug (IND) application for the first time? Consider three common CMC pitfalls that may impact submission.

Read Now
3 min. read
Read more
 
Case Study

World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed

Advarra’s IRB and IBC reviews and Gene Therapy Ready site network helped reduce study startup timelines and delivered trial results to the sponsor quicker than expected.

Read Now
Read more
 
Video

What Is an Institutional Biosafety Committee?

An institutional biosafety committee (IBC) ensures research is conducted safely and in compliance with the NIH guidelines. Watch our video to learn the role of an IBC.

Watch Now
Read more
 
Blog

Study Startup Success for BioPharma and MedTech: Engage a Research Compliance Partner

Engaging with an expert research compliance partner throughout the clinical development process allows researchers to focus on what matters

Read Now
3 min. read
Read more
 
Case Study

Meridian Builds Robust Gene Therapy Research Program

Partnering with Advarra’s Institutional Biosafety Committee, Meridian Clinical Research established a program for conducting clinical trials with cutting edge, genetically engineered vaccines.

Read Now
Read more